Skip to main content
OpenTrials

Clinical trial condition

Metastatic Prostate Carcinoma

Explore clinical trials studying Metastatic Prostate Carcinoma. Study availability and eligibility vary by location and protocol.

54 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Prostate Carcinoma trial results

Recruiting

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

NCT04489719

Conditions
Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Bozeman Health Deaconess Hospital Bozeman, Montana, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Wisconsin-Madison Madison, Wisconsin, United States
View Trial Details
Completed

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

NCT00942331

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +32 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 873 locations
View Trial Details
Completed

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

NCT03218826

Conditions
Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Prostate Carcinoma, +42 more
Locations
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

NCT04447703

Conditions
Biochemically Recurrent Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +12 more
Locations
  • VA New York Harbor Health System- Manhattan Campus New York, United States
  • New York University- Langone Health New York, United States
  • Associated Medical Professions of New York Syracuse, New York, United States
  • Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions